By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Complete Genomics reported after the close of the market Monday flat revenues year over year for the third quarter, but it beat analysts' consensus estimate for the top line.

The Mountain View, Calif.-based whole human genome sequencing services firm brought in total revenues of $4.2 million for the three-month period ended Sept. 30, even with revenues from Q3 2010. It beat the Wall Street forecast of $3.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.